港股時段，瑞聲科技(02018)盤中高見50.6元突破保力加通道頂部，現價報50.15元，升幅6.03%。股價強勢突破10日線(44.86元)、30日線(41.93元)及60日線 (40.45元)，技術面呈現「買入」信號，RSI 76進入超買區，威廉指標及隨機震盪指標同步發出買入訊號，但需警惕CCI指標出現超買狀態，短線可能面臨回 調壓力。 回顧上週五在專欄【港股Podcast】中有投資者問到瑞聲科技 (02018.HK)：投資者表示看好業績，下一波要帶量突破50-55元。Simon:走勢升穿保力加通道的 頂部。買賣信號為"買入"，短線向好一些。阻力位在48.5元和51.7元。有機會突破投資者期望的50元關口。 關鍵位攻防戰 即市支持位落在45.1元（支持1）及42.8元（支持2），上方阻力先看52元（阻力1），突破後有望挑戰56.2元（阻力2）。值得注意的是，5日振幅高達 12.6%，配合牛熊力量指標「中立」，反映市場對後市走勢仍存分歧。 國君認購證15427提供5.5倍槓桿，行使價54.73元，其溢價為同類最低，適合看好突破52元後續漲的投資者。中銀認購證18352行使價54.04元，雖然槓桿略低 至2. ...

Group 1 - The market perception that Trump favored a weaker dollar has shifted, with discussions around coordinated interventions like the "Mar-a-Lago Agreement" and "Plaza Accord 2.0" becoming less prominent as the dollar index surged [1][6] - On July 28, the dollar strengthened significantly against major currencies, driven by a tariff negotiation agreement between the US and EU, leading to increased selling of euros and buying of dollars [1][6] - The dollar index rose from 97.4-97.6 to 98.5-98.9, breaking through the 50-day moving average resistance level [1] Group 2 - Trump's recent statements indicate a preference for a strong dollar, contrasting with his previous criticisms of currency devaluation by countries like Japan and China [3][8] - The market is now considering the potential for a stronger dollar due to the robust state of the US economy, with expectations that the dollar could rise to 150 yen per dollar if the "America First" sentiment continues [6][8] - Technical analysis signals, such as the "Ichimoku Kinko Hyo," indicate bullish trends for the dollar, with key indicators showing strong signals for dollar appreciation [7][9]

Core Viewpoint - China Life Insurance (02628.HK) is experiencing a strong upward trend in its stock price, currently at 17.16 HKD, reflecting a 1.06% increase, following a rebound from a short-term support level of 16.2 HKD [1] Technical Analysis - The stock price has surpassed all major technical moving averages, including the 10-day moving average at 16.4 HKD, the 30-day moving average at 15.63 HKD, and the 60-day moving average at 15.23 HKD, indicating a bullish structure [1] - The stock is approaching the first resistance level at 17.3 HKD, with a potential target of 18.3 HKD if this level is breached [2] - The recent volatility is reflected in a 6.8% fluctuation over five days, with an RSI index at 72, indicating a technical overbought condition [3] - The overall technical indicators are rated as "strong buy," with a signal strength of 16 points, supported by bullish momentum across all categories [3] - The MACD has completed a golden cross and maintains an expanding trend, supporting a continued upward pattern [3] - The price has successfully broken through the Ichimoku cloud, suggesting further upward potential in the coming weeks [3] Derivative Products Performance - On June 6, China Life's related structured products performed well, with a 2.76% increase in the underlying stock, leading to significant gains in derivatives [4] - The Societe Generale bull certificate (53998) led with a 15% increase, outperforming the underlying stock, showcasing the leverage advantage of bull certificates in rising markets [4] Investment Options - Current market conditions provide diverse investment options through China Life's related structured products, with call options offering a leverage of 4.1 times [7] - Bull certificates from HSBC (53706) and JPMorgan (53835) offer over 5 times actual leverage, with a buyback price set at 14 HKD [7] - For bearish strategies, Citigroup's bear certificate (56865) offers a leverage of 4.7 times, with a buyback price set at 20 HKD, providing a favorable risk-reward ratio [7] Summary - China Life is in a healthy upward phase with strong volume-price support and trend indicator resonance, but caution is advised due to potential overbought conditions and divergence risks [10]